Brooks Laboratories Ltd (BROOKS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 539063,
    "name": "Brooks Lab.",
    "stock_name": "Brooks Lab.",
    "full_name": "Brooks Laboratories Ltd",
    "name_url": "stocks-analysis/brooks-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "69.97",
    "chg": 8.87,
    "chgp": "14.52%",
    "dir": 1,
    "prev_price": "61.10",
    "mcapval": "190.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 533543,
    "symbol": "BROOKS",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE650L01011",
    "curr_date": "Feb 09",
    "curr_time": "",
    "bse_nse_vol": "7.98 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 09, 2026",
    "traded_date_str": "2026 02 09",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/brooks-lab-539063-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Brooks Laboratories Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-hits-upper-circuit-amid-strong-buying-pressure-3828685",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BrooksLaborator_stocks_hitting_upper_circuit_3828685.png",
        "date": "2026-02-09 11:00:11",
        "description": "Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 9 Feb 2026, registering a maximum daily gain of 19.99%. The stock closed at ₹73.11, marking a significant turnaround after two consecutive days of decline, driven by robust buying interest and heightened volatility."
      },
      {
        "title": "Are Brooks Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-brooks-laboratories-ltd-latest-results-good-or-bad-3826830",
        "imagepath": "",
        "date": "2026-02-07 19:18:39",
        "description": "Brooks Laboratories Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported consolidated net sales of ₹16.57 crores, reflecting a notable decline of 29.34% quarter-on-quarter and 19.25% year-on-year. This marks the weakest top-line performance in eight quarters, raising concerns about demand sustainability and competitive positioning in the contract manufacturing sector.\n\nConsolidated net profit for the quarter stood at ₹5.50 crores, which represents a decline of 31.08% from the previous quarter. However, this figure is distorted by tax adjustments, as the profit quality appears compromised. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) fell sharply to ₹0.73 crores, indicating a 71.03% contraction from the prior quarter, with the operating margin dropping to 4.41%, the lowest in the past two years.\n..."
      },
      {
        "title": "Brooks Laboratories Q3 FY26: Sharp Revenue Decline Triggers Profit Concerns Despite Tax Write-Backs",
        "link": "https://www.marketsmojo.com/news/result-analysis/brooks-laboratories-q3-fy26-sharp-revenue-decline-triggers-profit-concerns-despite-tax-write-backs-3825780",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BrooksLaborator_quaterlyResult_3825780.png",
        "date": "2026-02-07 09:36:41",
        "description": "Brooks Laboratories Ltd., a micro-cap pharmaceutical contract manufacturer, reported a troubling third quarter for FY2026 with net sales plunging 29.34% quarter-on-quarter to ₹16.57 crores, marking the weakest quarterly revenue performance in recent history. Whilst consolidated net profit stood at ₹5.50 crores, this figure was artificially inflated by significant tax write-backs rather than genuine operational improvements, raising serious questions about the sustainability of the company's profitability trajectory."
      },
      {
        "title": "Are Brooks Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-brooks-laboratories-ltd-latest-results-good-or-bad-3824792",
        "imagepath": "",
        "date": "2026-02-06 19:21:30",
        "description": "Brooks Laboratories Ltd's latest financial results for Q2 FY26 present a mixed picture of performance. The company reported consolidated net sales of ₹23.45 crores, reflecting a sequential decline of 8.08% from ₹25.51 crores in Q1 FY26. This decrease in revenue is attributed to the inherent volatility in the contract manufacturing business, characterized by lumpy order flows. However, on a year-on-year basis, sales demonstrated resilience, growing by 12.79% compared to ₹20.79 crores in Q2 FY25.\n\nConsolidated net profit for the quarter was ₹7.98 crores, which marked a sequential decrease of 16.70% from ₹9.58 crores in the previous quarter. Despite this decline, the profit figure indicates a significant improvement from prior loss-making quarters, suggesting a turnaround in profitability. The company's operating margin, excluding other income, contracted to 10.75%, down from 12.23% in Q1 FY26, reflecting pres..."
      },
      {
        "title": "Brooks Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/brooks-laboratories-ltd-is-rated-sell-3824039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BrooksLaborator_mojoScore_3824039.png",
        "date": "2026-02-06 10:10:50",
        "description": "Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs 60",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-stock-falls-to-52-week-low-of-rs-60-3816445",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/BrooksLaborator_priceRelatedfactors_3816445.png",
        "date": "2026-02-02 11:19:32",
        "description": "Brooks Laboratories Ltd has touched a new 52-week low of Rs.60 today, marking a significant decline in its stock price amid ongoing challenges in its financial and market performance. The stock’s fall reflects persistent underperformance relative to its sector and benchmark indices."
      },
      {
        "title": "When is the next results date for Brooks Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-brooks-laboratories-ltd-3812062",
        "imagepath": "",
        "date": "2026-01-30 23:20:10",
        "description": "The next results date for Brooks Laboratories Ltd is scheduled for 06 February 2026...."
      },
      {
        "title": "Brooks Laboratories Ltd Falls to 52-Week Low of Rs.61.4 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-falls-to-52-week-low-of-rs614-amidst-continued-downtrend-3811707",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BrooksLaborator_priceRelatedfactors_3811707.png",
        "date": "2026-01-30 15:42:48",
        "description": "Brooks Laboratories Ltd has reached a new 52-week low of Rs.61.4, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors."
      },
      {
        "title": "Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs.62",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/brooks-laboratories-ltd-stock-falls-to-52-week-low-of-rs62-3809604",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/BrooksLaborator_priceRelatedfactors_3809604.png",
        "date": "2026-01-29 12:12:32",
        "description": "Brooks Laboratories Ltd touched a fresh 52-week low of Rs.62 today, marking a significant decline in its stock price amid ongoing challenges in its financial and market performance. The stock’s fall comes despite positive quarterly results, reflecting broader concerns about its long-term growth and valuation metrics."
      }
    ],
    "total": 269,
    "sid": "539063",
    "stock_news_url": "https://www.marketsmojo.com/news/brooks-laboratories-539063"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Feb-2026",
      "details": "Newspaper Publication dated 7th February 2026 of the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2025.",
      "datetime": "06-Feb-2026",
      "details": "Outcome of the Board Meeting held on Friday 6th February 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday 6Th February 2026.",
      "datetime": "06-Feb-2026",
      "details": "Outcome of Board Meeting held on Friday 6th February 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Brooks Laboratories Ltd has announced <strong>1:16</strong> rights issue, ex-date: 28 Jul 23",
          "dt": "2023-07-28",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Brooks Laboratories Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-09 11:00:11

Brooks Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit on 9 Feb 2026, registering a maximum daily gain of 19.99%. The stock closed at ₹73.11, marking a significant turnaround after two consecutive days of decline, driven by robust buying interest and heightened volatility.

Read full news article

Are Brooks Laboratories Ltd latest results good or bad?

2026-02-07 19:18:39

Brooks Laboratories Ltd's latest financial results for Q3 FY26 reveal significant operational challenges. The company reported consolidated net sales of ₹16.57 crores, reflecting a notable decline of 29.34% quarter-on-quarter and 19.25% year-on-year. This marks the weakest top-line performance in eight quarters, raising concerns about demand sustainability and competitive positioning in the contract manufacturing sector. Consolidated net profit for the quarter stood at ₹5.50 crores, which represents a decline of 31.08% from the previous quarter. However, this figure is distorted by tax adjustments, as the profit quality appears compromised. The operating profit before depreciation, interest, tax, and other income (PBDIT excluding other income) fell sharply to ₹0.73 crores, indicating a 71.03% contraction from the prior quarter, with the operating margin dropping to 4.41%, the lowest in the past two years. ...

Read full news article

Brooks Laboratories Q3 FY26: Sharp Revenue Decline Triggers Profit Concerns Despite Tax Write-Backs

2026-02-07 09:36:41

Brooks Laboratories Ltd., a micro-cap pharmaceutical contract manufacturer, reported a troubling third quarter for FY2026 with net sales plunging 29.34% quarter-on-quarter to ₹16.57 crores, marking the weakest quarterly revenue performance in recent history. Whilst consolidated net profit stood at ₹5.50 crores, this figure was artificially inflated by significant tax write-backs rather than genuine operational improvements, raising serious questions about the sustainability of the company's profitability trajectory.

Read full news article

Are Brooks Laboratories Ltd latest results good or bad?

2026-02-06 19:21:30

Brooks Laboratories Ltd's latest financial results for Q2 FY26 present a mixed picture of performance. The company reported consolidated net sales of ₹23.45 crores, reflecting a sequential decline of 8.08% from ₹25.51 crores in Q1 FY26. This decrease in revenue is attributed to the inherent volatility in the contract manufacturing business, characterized by lumpy order flows. However, on a year-on-year basis, sales demonstrated resilience, growing by 12.79% compared to ₹20.79 crores in Q2 FY25. Consolidated net profit for the quarter was ₹7.98 crores, which marked a sequential decrease of 16.70% from ₹9.58 crores in the previous quarter. Despite this decline, the profit figure indicates a significant improvement from prior loss-making quarters, suggesting a turnaround in profitability. The company's operating margin, excluding other income, contracted to 10.75%, down from 12.23% in Q1 FY26, reflecting pres...

Read full news article

Brooks Laboratories Ltd is Rated Sell

2026-02-06 10:10:50

Brooks Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs 60

2026-02-02 11:19:32

Brooks Laboratories Ltd has touched a new 52-week low of Rs.60 today, marking a significant decline in its stock price amid ongoing challenges in its financial and market performance. The stock’s fall reflects persistent underperformance relative to its sector and benchmark indices.

Read full news article

When is the next results date for Brooks Laboratories Ltd?

2026-01-30 23:20:10

The next results date for Brooks Laboratories Ltd is scheduled for 06 February 2026....

Read full news article

Brooks Laboratories Ltd Falls to 52-Week Low of Rs.61.4 Amidst Continued Downtrend

2026-01-30 15:42:48

Brooks Laboratories Ltd has reached a new 52-week low of Rs.61.4, marking a significant decline in its stock price amid broader market fluctuations and company-specific performance factors.

Read full news article

Brooks Laboratories Ltd Stock Falls to 52-Week Low of Rs.62

2026-01-29 12:12:32

Brooks Laboratories Ltd touched a fresh 52-week low of Rs.62 today, marking a significant decline in its stock price amid ongoing challenges in its financial and market performance. The stock’s fall comes despite positive quarterly results, reflecting broader concerns about its long-term growth and valuation metrics.

Read full news article

View All News